However, based on the lack of a clear trend in both that study and the other studies of different lengths included as part of this review, it is likely that most changes in CV risk are established early into treatment.
← all excerpts
Gender-affirming hormone therapy: effects on cardiovascular risk and vascular function.
1
—
—